Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

8, 2025 — Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease ... VU319 Brings Alzheimer's Treatment One Step Closer ...

The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

Biogen (BIIB) and Eisai's (ESALF) (ESAIY) announce that U.S. FDA agreed to review their subcutaneous form of Alzheimer's ...

Dr. Bayram says, overall, this study provides a promising step in advancing dementia prevention and care. "We are seeing more and more treatment trials that are focused on disease modification for ...

Some research shows it may have benefits for people with Alzheimer’s disease, but current evidence is mixed. Melatonin is a hormone produced by a small gland in your brain called the pineal gland.

The findings were alarming. People who took at least one anticholinergic drug had a 47% higher risk of developing memory ...